Text Size: a  |   a 

Medical Marijuana Chewing Gum

August 19, 2015

While many have turned to marijuana in order to ease pain and spasticity of multiple sclerosis, there may be a new way patients can alleviate their symptoms with the drug. Even if you’ve never been a fan of the concept, you may find yourself wanting to try chewing the medical cannabis-based gum that could possibly be hitting the market soon.

A biotech company that focuses on cannabis, AXIM Biotechnologies, said it launched clinical trials on humans for the chewing gum to act as a treatment for multiple sclerosis. While the trials that are being held are strictly for MS patients, Axim does hope to expand the range of conditions it can be prescribed for. MedChew RX gum contains 5 milligrams of cannabidiol which is a non-psychoactive component of cannabis and 5 milligrams of THC, which is a psychoactive cannabinoid.

The gum is expected to have a predictable and controlled release of the active ingredients that should have a pleasing taste as well as consistency, along with no undesirable side effects. The act of chewing not only helps promote one’s overall oral health, it also helps to preserve cognition and memory.

The Phase 1 trial of this product is to begin in the second quarter of 2016. While the FDA has not approved any product containing cannabis yet, it has approved Marinol, which contains a synthesized form of THC. This is used for anorexia, chemotherapy and AIDS patients.

 

There is no ambiguity as to where the gum is legal, therefore the company is going through the FDA. The FDA says it will continue to assess marijuana’s effectiveness for medical use and will work with companies to conduct more research on medical cannabis. If approved, the chewing gum could be available to patients in all 50 states even if medical marijuana has not been legalized yet. 

Medical Marijuana Chewing Gum - Wed August 19, 2015 2:10 PM